Skip to main content
Journal of Cardiothoracic Surgery logoLink to Journal of Cardiothoracic Surgery
letter
. 2023 Jan 20;18:42. doi: 10.1186/s13019-023-02147-y

The poorly understood yet potent risk of pulmonary artery thrombosis in-situ in Post-Acute COVID-19 syndrome

Alvin Oliver Payus 1,, Constance Liew Sat Lin 1, Azliza Ibrahim 2
PMCID: PMC9851892  PMID: 36658637

Abstract

Pulmonary artery thrombosis in-situ is a term used to describe a pulmonary embolism occurs in the absence of deep vein thrombosis in the lower extremities. Most cases occur in a patient who had a recent traumatic injury to the chest. Other risk factors include the presence of hypercoagulable conditions, including inflammatory state, hypoxia and vascular endothelial injury. Although it has been discussed extensively in the acute COVID-19 disease, pulmonary artery thrombosis in-situ that occur in the setting of Post-Acute COVID-19 syndrome is not commonly reported and poorly understood.


We read with great interest the article by Alrifae GM et al., entitled “Post-Acute COVID-19 syndrome (PACS) right atrioventricular and vena cava thrombus on top of a myxoma. A Case report " which was recently published in the volume 17, Article: 261 (2022) [1]. Firstly, we would like to praise the authors for their effort in describing a case of coronavirus disease 2019 (COVID-19)-related intracardiac thrombosis encasing a cardiac myxoma in the setting of post-acute phase of COVID-19 syndrome. The authors have nicely written the case in great detail and conclude the occurrence of intracardiac thrombosis in atrial myxoma as a sequalae of COVID-19 which occurs four months prior this presentation. We strongly support the statement by the authors that thrombosis can developed in situ, especially in the background of hyperinflammatory condition, like COVID-19 which leads to hypercoagulable state [2, 3]. However, there is some important information that is missing in the article, which is the background history of the patient during her COVID-19 illness especially her inflammatory markers, and also the list of regular medication that she is taking. We believe this information is vital to determine the aetiology and prognosis of the condition. Apart from that, we believe a follow-up reporting is warranted on the rate and status of recovery after rehabilitation and the presence of other PACS symptoms. Nevertheless, we agree with the authors that intracardiac thrombosis that occur over cardiac myxomas as a sequalae of PACS have not been well described in the literature. Therefore, we believe this study will be a potential catalyst to trigger future studies to improve the treatment and prevention of thrombosis and other cardiovascular complications associated with COVID-19.

Acknowledgements

The authors would like to thank the Director General of Health Malaysia for his permission to publish this article.

Author contributions

AOP is the main author of this article, CLSL helps with the writing of the manuscript, collect information and review literature, AI supervise the whole writing process. All authors reviewed the manuscript.

Funding

Not applicable.

Availability of data and materials

Not applicable.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Alrifae GM, Almuquddami AA, Etaleb KM, Abdelhamid MH. Post-Acute COVID-19 syndrome (PACS) right atrioventricular and vena cava thrombus on top of a myxoma. A Case report. J Cardiothorac Surg. 2022;17(1):1–6. doi: 10.1186/s13019-022-01998-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Payus AO, Rajah R, Febriany DC, Mustafa N. Pulmonary embolism masquerading as severe pneumonia: a case report. Open Access Maced J Med Sci. 2019;7(3):396. doi: 10.3889/oamjms.2019.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.He DK, Zhang YF, Liang Y, Ye SX, Wang C, Kang B, Wang ZN. Risk factors for embolism in cardiac myxoma: a retrospective analysis. Medical science monitor. Int Med J Exp Clin Res. 2015;21:1146. doi: 10.12659/MSM.893855. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Not applicable.


Articles from Journal of Cardiothoracic Surgery are provided here courtesy of BMC

RESOURCES